AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$15.83
Tradestie Score
49
Market Cap
$1.50B
P/E Ratio
7.0
Revenue Growth
0.2%
Analyst Upside
+12.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$4.12
|
$2.23B | - | 32 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$28.35
|
$2.22B | - | 50 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.93
|
$2.21B | - | 58 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.00
|
$2.18B | - | 65 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.08
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.50
|
$2.02B | - | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.26
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.02
|
$1.97B | - | 52 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.96
|
$1.92B | - | 51 | Compare |
More AUPH Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry